IRDAI Wants To Reduce Conditions Excluded From Health Insurance
The insurance regulator seeks to reduce and standardise the number of health conditions and medical procedures excluded from health insurance policies.
The Insurance Regulatory and Development Authority of India, in an order uploaded on its website yesterday, said it has formed a working group to examine the issue. The panel—chaired by Suresh Mathur, executive director (health) at IRDAI, and comprising representatives of insurers—will submit its suggestions in eight weeks.
“We welcome a comprehensive review of exclusions as it would improve coverage for customers,” said Puneet Sahni, head of product development at SBI General Insurance Company. The insurers, he said, should be given the option to modify premium pricing based on the exclusions provided at the time of underwriting the business.
Most health insurance plans exclude pre-existing diseases, cosmetic and dental surgeries, pregnancy, vaccination, intentional injuries, HIV and alternative treatments such as homeopathy and ayurveda. In February this year, the Delhi High Court ruled that insurers can't exclude genetic disorders and congenital anomalies, calling it a “violation of citizens' right to health”.
The regulator now wants to standardise exclusions in health policies. The objectives of the group set up by it include:
- Rationalise the exclusions by minimising the number to enhance the scope of health insurance coverage granted.
- Remove exclusions that disallow coverage “with respect to new modalities of treatments and technologically advanced medical treatments”.
- Study the scope of allowing exclusions specific to individuals and diseases at the time of underwriting business.
- Provide a uniform framework for standalone health and general insurers to incorporate exclusions in their policies.
- Standardise the language used by companies to list their exclusions.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
-
Why Amazon And Flipkart Are Struggling To Beat Meesho In India's Smaller Cities
With 274 million users and lowest-cost logistics, Meesho is defending its value commerce crown against giants like Amazon and Flipkart.